Table 1. Baseline demographics of patients treated with PVI 5FU.

	Number	Percentage
Total	1470	100.0
PVI 5FU alone	861	58.6
PVI 5FU plus MMC	609	41.4
Male	833	56.7
Female	637	43.3
Performance status 0–1	1081	73.6
Performance status 2–3	364	24.8
Unknown performance status	25	1.7
Age: median (range)	64 (24–86)
Palliative treatment	1131	76.9
Adjuvant treatment	339	23.1
Primary tumour
Oesophago-gastric	172	11.7
Colorectal	955	65.0
Pancreas	245	16.7
Unknown primary	98	6.7